Biden administration should prioritize innovation in U.S.-Taiwan Initiative on 21st-Century Trade

Last summer, the United States and Taiwan launched the U.S.-Taiwan Initiative on 21st-Century Trade to deepen economic and trade relations. In detailed comments to the U.S. Trade Representative...
Read More
PhRMA submission to USTR calls for urgent defense of American innovation abroad

The United States leads the world in medicine research, development and manufacturing, and international trade delivers those medicines to patients around the globe. But trade barriers imposed in...
Read More
Partnerships are driving global COVID-19 treatment access

Through the constant efforts of U.S. innovators and their global partners, COVID-19 treatments have continued to be distributed to patients around the world — changing the pandemic’s treatment...
Read More
The dangers of expanding the TRIPS waiver

World Trade Organization (WTO) members, including the United States, are considering waiving commitments to honor certain intellectual property (IP) rights on COVID-19 treatments, following a harmful...
Read More
Biden Administration details inadequate protection of American intellectual property and foreign barriers to innovation abroad

More than two years into the COVID-19 pandemic, the world has witnessed the immense value of biopharmaceutical innovation. With numerous safe and effective vaccines and treatments developed in record...
Read More
PhRMA encourages Biden administration to pursue ambitious Indo-Pacific Economic Framework

Last fall, President Biden announced that the United States would explore development of an Indo-Pacific Economic Framework (IPEF) to deepen economic relations in the region and collaborate to...
Read More
PhRMA submission to 2022 National Trade Estimate Report underscores need for pro-innovation U.S. trade policy to combat COVID-19 and other diseases

The biopharmaceutical industry has been working tirelessly to develop and manufacture innovative vaccines, therapies and diagnostics to combat COVID-19 and other diseases and illnesses. As of October...
Read More
Strengthening the WTOs global trade and health agenda

The World Trade Organization (WTO) should use the weeks ahead to focus on delivering an ambitious and productive trade and health agenda as it prepares for the Twelfth Ministerial Conference (MC12)...
Read More
New polling shows Americans are sounding the alarm on the TRIPS IP waiver

Last week, the Biden administration announced support for a waiver of the World Trade Organization (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement, which could lead to...
Read More
The Biden Administration allows politics to upend a pragmatic pandemic response

Last week, the Biden Administration announced that it will support a waiver of the World Trade Organization (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement, which would...
Read More